Improving the Prescribing of Medications at the End of Life in Long-term Care Homes during the COVID-19 Pandemic

Principal Investigator
Dr. Peter Tanuseputro & Dr. Sarina Isenberg
Bruyère Research Institute
Study Contact
Dr. Peter Tanuseputro
Project Lay Summary

The average survival time in long-term care is 18 months, meaning that palliative care essential for long-term care residents. A central component of palliative care is symptom management to provide a comfortable death. Symptom management could be an indicator of the quality of palliative care provision. We are exploring patterns of prescribing of end-of-life symptom management medications in long-term care homes across Ontario and Alberta. Specifically, we are analyzing health administrative data on prescriptions for symptom management medications. Additionally, we are interviewing healthcare providers and bereaved caregivers of long-term care residents to gain a better understanding of the observed prescribing patterns, and factors that may contribute to these patterns. This project will allow us to identify enablers and barriers to prescribing symptom management medications for residents nearing the end of life and help identify long-term care homes that may need additional support

Project Details
Non-Drug Study
Alberta, Ontario
Research Topics
Symptom Management, Health Services
Pain, Nausea, Shortness of Breath, Anxiety, Palliative Care and COVID-19, Timely Identification of Palliative Needs, Long-term Care
Target Groups
Family Caregivers, Healthcare Providers

Check out more of our studies.

Patients and Caregivers